rs863225269
Variant summary
Our verdict is Pathogenic. The variant received 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_002471.4(MYH6):c.3193dupC(p.Gln1065ProfsTer10) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_002471.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathy 14Inheritance: AD Classification: STRONG, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, Laboratory for Molecular Medicine
- Keppen-Lubinsky syndromeInheritance: AD Classification: MODERATE Submitted by: Illumina
- familial isolated dilated cardiomyopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- atrial septal defect 3Inheritance: AD Classification: LIMITED Submitted by: G2P
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- hypertrophic cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 12 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| MYH6 | NM_002471.4 | c.3193dupC | p.Gln1065ProfsTer10 | frameshift_variant | Exon 24 of 39 | ENST00000405093.9 | NP_002462.2 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| MYH6 | ENST00000405093.9 | c.3193dupC | p.Gln1065ProfsTer10 | frameshift_variant | Exon 24 of 39 | 5 | NM_002471.4 | ENSP00000386041.3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy 1 Pathogenic:1
This MYBPC3 Lys1065fs variant results from a single bp insertion, which is predicted to cause a frameshift at codon 1065 and premature stop codon 12 amino acids downstream. This alteration is predicted to lead to a truncated or absent protein. This variant is absent from population datasets including the 1000 genomes project (http://www.1000genomes.org/) and the Exome Aggregation Consortium dataset (http://exac.broadinstitute.org/). MYBPC3 Lys1065fs has been identified in multiple unrelated HCM cases (see references). We have identified the this variant in one male HCM patient. Familial segregation revealed his affected nephew to also carried this variant. Based on the absence of this variant in the general population, observations of the variant in multiple unrelated HCM patients reported in the literature, and that loss-of-function variants in MYBPC3 are an established mechanism of disease in HCM, we classify MYBPC3 Lys1065fs as "pathogenic". -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at